Prof. Dr. BARIŞ AKINCI

Yayın Ağı

Makaleler 140

1. Metreleptin In SHORT Syndrome With Uncontrolled Diabetes

Korakas E., Kountouri A., Ikonomidis I., Georgiou I., AKINCI B., Lambadiari V.

JCEM Case Reports , cilt.3, sa.11, 2025 (Scopus)

2. Epidemiological and clinical data from the European Lipodystrophy Registry

Ceccarini G., Vatier C., AKINCI B., Belalem I., Broekema M., Csajbok E., et al.

European Journal of Endocrinology , cilt.193, sa.5, ss.685-703, 2025 (SCI-Expanded, Scopus)

3. Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy

Brown R. J., AKINCI B., Yosef M., Phillips H., Khalatbari S., Sorkina E., et al.

Journal of Clinical Endocrinology and Metabolism , cilt.110, sa.11, ss.3243-3255, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome

Gilio D., Besci Ö., Guidorizzi N. R., Guler M. C., YILDIRIM ŞİMŞİR I., Pelosini C., et al.

CLINICAL ENDOCRINOLOGY , cilt.103, sa.4, ss.504-512, 2025 (SCI-Expanded, Scopus)

5. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20–21 May 2025

Vatier C., Araújo-Vilar D., AKINCI B., Arnould T., Beaupère C., Bismuth E., et al.

Annales d'Endocrinologie , cilt.86, sa.5, 2025 (SCI-Expanded, Scopus)

6. Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response

Akinci B., Ajluni N., Meral R., Neidert A. H., Freitas M. F., Gilio D., et al.

Journal of the Endocrine Society , cilt.9, sa.8, 2025 (ESCI, Scopus)

7. Genetics Evaluation Outcomes from an Academic Multidisciplinary Atypical Diabetes Program

Chase C. L., Accardo M., Greve V., Ames E. G., Quinonez S. C., Scott A., et al.

Journal of the Endocrine Society , cilt.9, sa.8, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

8. Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy

Beghini M., Metz M., Baumgartner C., Wolf P., Bastian M., Hackl M., et al.

Metabolism: Clinical and Experimental , cilt.169, 2025 (SCI-Expanded, Scopus)

9. Assessment of aortomesenteric distance and mesenteric and retroperitoneal adipose tissue thickness in genetic forms of lipodystrophy

ÜNAL M. Ç., UNCUOĞLU F., GÜNGÖR SEMİZ G., ARAYICI M. E., Yener S., ALTAY C., et al.

Journal of Endocrinological Investigation , cilt.48, sa.2, ss.445-454, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions

Brown R. J., AKINCI B., Al Yaarubi S., Bismuth E., Cappa M., Deeb A., et al.

Frontiers in Endocrinology , cilt.16, 2025 (SCI-Expanded, Scopus)

11. A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy

Brown R. J., Araujo-Vilar D., Walkovich K. J., Barbarosie A., Magee D. A., Akinci B., et al.

Frontiers in Endocrinology , cilt.16, 2025 (SCI-Expanded, Scopus)

12. Impact of lipodystrophy on health-related quality of life: the QuaLip study

Demir T., Simsir I. Y., Tuncel O. K., Ozbaran B., Yildirim I., Pirildar S., et al.

Orphanet Journal of Rare Diseases , cilt.19, sa.1, 2024 (SCI-Expanded, Scopus)

13. Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey

Patni N., Chard C., Araújo-Vilar D., Phillips H., Magee D. A., AKINCI B.

Orphanet Journal of Rare Diseases , cilt.19, sa.1, 2024 (SCI-Expanded, Scopus)

14. A cohort analysis of familial partial lipodystrophy from two Mediterranean countries

Fernández-Pombo A., Yildirim Simsir I., Sánchez-Iglesias S., Ozen S., Castro A. I., Atik T., et al.

Diabetes, Obesity and Metabolism , cilt.26, sa.11, ss.4875-4886, 2024 (SCI-Expanded, Scopus)

15. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip), Pisa, Italy, 28–29 September 2023

Ceccarini G., AKINCI B., Araujo-Vilar D., Beghini M., Brown R. J., Carrion Tudela J., et al.

Annales d'Endocrinologie , cilt.85, sa.4, ss.308-316, 2024 (SCI-Expanded, Scopus)

16. Metabolic and other morbid complications in congenital generalized lipodystrophy type 4

Akinci G., Alyaarubi S., Patni N., Alhashmi N., Al-Shidhani A., Prodam F., et al.

American Journal of Medical Genetics, Part A , cilt.194, sa.6, 2024 (SCI-Expanded, Scopus)

17. A rapid action plan to improve diagnosis and management of lipodystrophy syndromes

Fourman L. T., Lima J. G., Simha V., Cappa M., Alyaarubi S., Montenegro R., et al.

Frontiers in Endocrinology , cilt.15, 2024 (SCI-Expanded, Scopus)

18. Clinical features of generalized lipodystrophy in Turkey: A cohort analysis

Yildirim Simsir I., TÜYSÜZ B., Ozbek M. N., Tanrikulu S., ÇELİK GÜLER M., Karhan A. N., et al.

Diabetes, Obesity and Metabolism , cilt.25, sa.7, ss.1950-1963, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. The subtleties of insulin treatment in patients with lipodystrophy

ŞİMŞİR I. Y., SOYALTIN U. E., ÇETİNKALP Ş., AKINCI B.

Ege Tıp Dergisi , cilt.62, sa.1, ss.164-168, 2023 (TRDizin)

20. A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature

Mancioppi V., Daffara T., Romanisio M., Ceccarini G., Pelosini C., Santini F., et al.

Frontiers in Endocrinology , cilt.14, 2023 (SCI-Expanded, Scopus)

21. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Cambridge, UK, 7-8 April 2022

Mosbah H., AKINCI B., Araujo-Vilar D., Carrion Tudela J., Ceccarini G., Collas P., et al.

ANNALES D ENDOCRINOLOGIE , cilt.83, sa.6, ss.461-468, 2022 (SCI-Expanded, Scopus)

22. NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC

ÜNAL M. Ç., Semiz G., ÖZDOĞAN Ö., ALTAY C., YILDIRIM E., SEMİZ H. S., et al.

ACTA ENDOCRINOLOGICA-BUCHAREST , cilt.18, sa.4, ss.516-522, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. A National Multicenter Study of Leptin (LEP) and Leptin Receptor (LEPR) Deficiency and a Systematic Review of Patients with Pathogenic LEP/LEPR Variants

BESCİ Ö., Firat S. N., ÖZEN S., Cetinkaya S., Akin L., Kor Y., et al.

HORMONE RESEARCH IN PAEDIATRICS , cilt.95, sa.SUPPL 2, ss.239, 2022 (SCI-Expanded, Scopus)

24. European Consortium of Lipodystrophies Registry, 2022

von Schnurbein J., Gambinieri A., Fernandez-Pombo A., AKINCI B., Vatier C., Cecchetti C., et al.

HORMONE RESEARCH IN PAEDIATRICS , cilt.95, sa.SUPPL 2, ss.77-78, 2022 (SCI-Expanded, Scopus)

25. Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes

Gautheron J., Lima L., AKINCI B., Zammouri J., Auclair M., Ucar S. K., et al.

BMC MEDICINE , cilt.20, sa.1, 2022 (SCI-Expanded, Scopus)

26. Simultaneous Teamwork May Improve Hypoglycemia Rates in Patients with Type 1 Diabetes Using an Insulin Pump

ÖZGEN SAYDAM B., ADIYAMAN S. C., YEŞİLLİ B., Bektas A. B., Vatansever O., Aydin N., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.26, sa.1, ss.13-22, 2022 (ESCI, Scopus, TRDizin)

27. Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

Agcaoglu O., Sezer A., MAKAY Ö., Erdogan M. F., BAYRAM F., GÜLDİKEN S., et al.

UPDATES IN SURGERY , cilt.74, sa.1, ss.325-335, 2022 (SCI-Expanded, Scopus)

28. Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study

Foss-Freitas M. C., Akinci B., Neidert A., Bartlett V. J., Hurh E., Karwatowska-Prokopczuk E., et al.

LIPIDS IN HEALTH AND DISEASE , cilt.20, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Complications of lipodystrophy syndromes

Akinci G., ÇELİK M., AKINCI B.

PRESSE MEDICALE , cilt.50, sa.3, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis

Cook K., Ali O., AKINCI B., Foss de Freitas M. C., Montenegro R. M., Fernandes V. O., et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.106, sa.8, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Association of Leptin Levels and Disease Activity in Patients with Early Rheumatoid Arthritis

Taylan A., AKINCI B., Toprak B., Birlik M., Arslan F. D., Ekerbicer H., et al.

ARCHIVES OF MEDICAL RESEARCH , cilt.52, sa.5, ss.544-553, 2021 (SCI-Expanded, Scopus)

32. Diabetic Foot Ulcers: A Neglected Complication of Lipodystrophy

Saydam O., Ozgen Saydam B., ADIYAMAN S. C., Sonmez Ince M., EREN M. A., Keskin F. E., et al.

DIABETES CARE , cilt.43, sa.10, 2020 (SCI-Expanded, Scopus)

33. Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy

YILDIRIM ŞİMŞİR I., ŞARER YÜREKLİ B. P., Polat I., Saygili F., AKINCI B.

NATIONAL MEDICAL JOURNAL OF INDIA , cilt.33, sa.5, ss.278-280, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy

ALTAY C., SEÇİL M., ADIYAMAN S. C., Saydam B. O., DEMİR T., Akinci G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, sa.8, ss.588-595, 2020 (SCI-Expanded, Scopus, TRDizin)

35. Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People

ÖZEN S., AKINCI B., Oral E. A.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , cilt.12, sa.1, ss.17-28, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Diagnostic strategies and clinical management of lipodystrophy

Foss-Freitas M. C., AKINCI B., Luo Y., Stratton A., Oral E. A.

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM , cilt.15, sa.2, ss.95-114, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

37. The Role of Adiponectin in Maintaining Metabolic Homeostasis

ADIYAMAN S. C., Ozer M., Saydam B. O., AKINCI B.

CURRENT DIABETES REVIEWS , cilt.16, sa.2, ss.95-103, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

38. European lipodystrophy registry: background and structure

Von Schnurbein J., Adams C., AKINCI B., Ceccarini G., D'Apice M. R., Gambineri A., et al.

ORPHANET JOURNAL OF RARE DISEASES , cilt.15, sa.1, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study

AKINCI B., Oral E. A., Neidert A., Rus D., Cheng W. Y., Thompson-Leduc P., et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.104, sa.11, ss.5117-5132, 2019 (SCI-Expanded, Scopus)

40. An overview of lipodystrophy and the role of the complement system

Corvillo F., AKINCI B.

MOLECULAR IMMUNOLOGY , cilt.112, ss.223-232, 2019 (SCI-Expanded, Scopus)

41. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: A potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors

Taylan A., Birlik M., Kenar G., Toprak B., Gundogdu B., Gurler O., et al.

MODERN RHEUMATOLOGY , cilt.29, sa.4, ss.619-624, 2019 (SCI-Expanded, Scopus)

42. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

AKINCI B.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.380, sa.19, ss.1881, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities

Saydam B. O., Sonmez M., YILDIRIM ŞİMŞİR I., Erturk M. S., KULAKSIZOĞLU M., Arkan T., et al.

ENDOCRINE RESEARCH , cilt.44, ss.46-54, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. AN UNUSUAL CASE OF ACQUIRED PARTIAL LIPODYSTROPHY PRESENTING WITH ACANTHOSIS NIGRICANS

Kutbay N. O., Yurekli B. S., Yasar Z., AKINCI B.

ACTA ENDOCRINOLOGICA-BUCHAREST , cilt.15, sa.1, ss.129-130, 2019 (SCI-Expanded, Scopus)

45. Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities

AKINCI B., Meral R., Oral E. A.

CURRENT DIABETES REPORTS , cilt.18, sa.12, 2018 (SCI-Expanded, Scopus)

46. Update on Therapeutic Options in Lipodystrophy

AKINCI B., Meral R., Oral E. A.

CURRENT DIABETES REPORTS , cilt.18, sa.12, 2018 (SCI-Expanded, Scopus)

47. "Fat Shadows" From DXA for the Qualitative Assessment of Lipodystrophy: When a Picture Is Worth a Thousand Numbers

Meral R., Ryan B. J., Malandrino N., Jalal A., Neidert A. H., Muniyappa R., et al.

DIABETES CARE , cilt.41, sa.10, ss.2255-2258, 2018 (SCI-Expanded, Scopus)

48. Does the ACR TI-RADS scoring allow us to safely avoid unnecessary thyroid biopsy? single center analysis in a large cohort

Atilla F. D. K., Saydam B. O., Erarslan N. A., Unlu A. G. D., Yasar H. Y., Ozer M., et al.

ENDOCRINE , cilt.61, sa.3, ss.398-402, 2018 (SCI-Expanded, Scopus)

49. Renal complications of lipodystrophy: A closer look at the natural history of kidney disease

AKINCI B., ÜNLÜ Ş. M., Celik A., YILDIRIM ŞİMŞİR I., ŞEN S., NUR B., et al.

CLINICAL ENDOCRINOLOGY , cilt.89, sa.1, ss.65-75, 2018 (SCI-Expanded, Scopus)

50. Airway and sleep disorders in patients with acromegaly

Turan O., AKINCI B., İKİZ A. Ö., Itil O., ÖZTURA İ., ADA E., et al.

CLINICAL RESPIRATORY JOURNAL , cilt.12, sa.3, ss.1003-1010, 2018 (SCI-Expanded, Scopus)

51. Cytologic Comparison Between Growing and Non-growing Benign Thyroid Nodules Evaluated Using Two Different Growth Criteria

Yalcin M. M., Yesil S., AKINCI B., BAYRAKTAR F., ÇÖMLEKÇİ A., Unal S., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.22, sa.1, ss.16-20, 2018 (ESCI, Scopus, TRDizin)

52. A Rare Case of Diabetes Mellitus in an Adolescent: Partial Lipodystrophy

ÖZEN S., ATA A., Goksen D., AKINCI B., Tuncer C. A., DARCAN Ş.

HORMONE RESEARCH IN PAEDIATRICS , cilt.90, ss.309, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. A new type of familial partial lipodystrophy: distinctive fat distribution and proteinuria

Yurekli B., Kutbay N. O., ALTAY C., ÜNLÜ Ş. M., ŞEN S., Onay H., et al.

ENDOCRINE RESEARCH , cilt.43, sa.4, ss.258-263, 2018 (SCI-Expanded, Scopus)

54. Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy

ALTAY C., SEÇİL M., DEMİR T., Atik T., Akinci G., Kutbay N. O., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.23, sa.6, ss.428-434, 2017 (SCI-Expanded, Scopus, TRDizin)

55. Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study

Akinci G., Topaloglu H., DEMİR T., ERŞEN DANYELİ A., TALİM B., Keskin F. E., et al.

NEUROMUSCULAR DISORDERS , cilt.27, sa.10, ss.923-930, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy

AKINCI B., Onay H., DEMİR T., Savas-Erdeve S., GEN R., YILDIRIM ŞİMŞİR I., et al.

METABOLISM-CLINICAL AND EXPERIMENTAL , cilt.72, ss.109-119, 2017 (SCI-Expanded, Scopus)

57. First metreleptin treatment for generalized lipodystrophy in Turkey

YILDIRIM ŞİMŞİR I., ŞARER YÜREKLİ B. P., Saygili F., ALTAY C., AKINCI B.

DIABETES OBESITY & METABOLISM , cilt.19, sa.2, ss.299-301, 2017 (SCI-Expanded, Scopus)

58. Progeroid syndrome patients with ZMPSTE24 deficiency could benefit when treated with rapamycin and dimethylsulfoxide

AKINCI B., Sankella S., Gilpin C., Ozono K., Garg A., Agarwal A. K.

COLD SPRING HARBOR MOLECULAR CASE STUDIES , cilt.3, sa.1, 2017 (ESCI, Scopus)

59. The Effect of Retraining on Treatment Success, Quality of Life, and Metabolic Parameters in Patients with Type 1 Diabetes Using an Insulin Pump

Saydam B. O., Yilmazmis F., Aydin N., Bektas B., Yilmaz S., Cavdar U., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.26, sa.4, ss.325-330, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. MEAN PLATELET VOLUME AND PLATELET FUNCTION ANALYSIS IN ACROMEGALIC PATIENTS BEFORE AND AFTER TREATMENT

Demirpence M., Yasar H. Y., Colak A., AKINCI B., Yener S., Toprak B., et al.

ACTA ENDOCRINOLOGICA-BUCHAREST , cilt.12, sa.4, ss.401-406, 2016 (SCI-Expanded, Scopus)

61. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -gamma (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations

Demir T., Onay H., Savage D. B., Temeloglu E., KUBAT ÜZÜM A., Kadioglu P., et al.

DIABETIC MEDICINE , cilt.33, sa.10, ss.1445-1450, 2016 (SCI-Expanded, Scopus)

62. Partial lipodystrophy of the limbs in a diabetes clinic setting

DEMİR T., AKINCI B., Demir L., ALTAY C., ATİK T., Cavdar U., et al.

PRIMARY CARE DIABETES , cilt.10, sa.4, ss.293-299, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Mean Platelet Volume in Women with Gestational Diabetes

Celtik A., AKINCI B., DEMİR T.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.20, sa.2, ss.48-53, 2016 (ESCI, Scopus, TRDizin)

64. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4

Akinci G., Topaloglu H., AKINCI B., Onay H., Karadeniz C., Ergul Y., et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS , cilt.59, ss.320-324, 2016 (SCI-Expanded, Scopus)

65. Endothelium-Dependent Hemostatic Factors in Women with Previous Gestational

DEMİR T., AKINCI B., Yener S., Argun L., ÖZCAN M. A., Eraslan S.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.20, sa.2, ss.43-47, 2016 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

66. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA)mutation in exon 1 (D47N)

Kutbay N. O., ŞARER YÜREKLİ B. P., Onay H., ALTAY C., ATİK T., HEKİMSOY Z., et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , cilt.29, ss.37-39, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Endothelium Dependent Hemostatic Factors in Previous Gestational Diabetes Mellitus

DEMİR T., AKINCI B., YENER A. S., ARGUN L., ÖZCAN M. A., ERASLAN S.

Turkish Journal of Endocrinology and Metababolism , cilt.20, 2016 (ESCI)

68. Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities

AKINCI B., Koseoglu F. D., Onay H., Yavuz S., ALTAY C., YILDIRIM ŞİMŞİR I., et al.

METABOLISM-CLINICAL AND EXPERIMENTAL , cilt.64, sa.9, ss.1086-1095, 2015 (SCI-Expanded, Scopus)

69. SPG11 mutation in a Turkish familial hypobetalipoproteinemia family with hereditary spastic paraplegia

Hooper A. J., AKINCI B., Davis M. R., Burnett J. R.

Clinica Chimica Acta , cilt.445, ss.1, 2015 (SCI-Expanded, Scopus)

70. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy

Akinci G., AKINCI B.

RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY , cilt.9, sa.2, ss.74-78, 2015 (ESCI, Scopus) Sürdürülebilir Kalkınma

71. Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid

AKINCI B., Terzi C., Sevindik G., Yuksel F., Tunc U. A., Tunali S., et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS , cilt.28, sa.6, ss.844-849, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes

AKINCI B., ÇELTİK A., TUNALI S., Genc S., YÜKSEL F., SEÇİL M., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , cilt.289, sa.4, ss.787-793, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes

Colak A., AKINCI B., Diniz G., Turkon H., Ergonen F., Yalcin H., et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , cilt.73, sa.5, ss.422-427, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis

Taylan A., SARI İ., AKINCI B., Bilge S., Kozaci D., Akar S., et al.

BMC MUSCULOSKELETAL DISORDERS , cilt.13, 2012 (SCI-Expanded, Scopus)

75. Insulin Need in Gestational Diabetes is Associated with a Worse Cardiovascular Risk Profile after Pregnancy

BAYRAKTAR F., AKINCI B., ÇELTİK A., TUNALI S., Genc S., ÖZCAN M. A., et al.

INTERNAL MEDICINE , cilt.51, sa.8, ss.839-843, 2012 (SCI-Expanded, Scopus)

76. Increased Risk of Unfavorable Metabolic Outcome during Short-Term Follow-Up in Subjects with Nonfunctioning Adrenal Adenomas

Yener S., Ertilav S., SEÇİL M., AKINCI B., Demir T., Kebapcilar L., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.21, sa.5, ss.429-434, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. A Puzzling Case of Phospho-Soda-induced Hypocalcemia in a Patient with Multiple Endocrine Neoplasia Type 1-associated Primary Hyperparathyroidism

Ozveren A., AKINCI B., MAKAY Ö., SARSIK KUMBARACI B., YILDIRIM ŞİMŞİR I., BERDELİ A., et al.

INTERNAL MEDICINE , cilt.51, sa.22, ss.3145-3149, 2012 (SCI-Expanded, Scopus)

78. Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes

AKINCI B., ÇELTİK A., Yener S., Genc S., TUNALI S., YÜKSEL F., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.17, sa.6, 2011 (SCI-Expanded, Scopus)

79. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes

AKINCI B., ÇELTİK A., Genc S., Yener S., DEMİR T., SEÇİL M., et al.

GYNECOLOGICAL ENDOCRINOLOGY , cilt.27, sa.5, ss.361-367, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?

Yener S., BARIŞ M. M., SEÇİL M., AKINCI B., Comlekci A., Yesil S.

Journal of endocrinological investigation , cilt.34, sa.4, ss.265-70, 2011 (SCI-Expanded, Scopus)

81. Effect of Levothyroxine Suppression Therapy on Plasma Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels in Benign Thyroid Nodules

AKINCI B., DEMİR T., ÇÖMLEKÇİ A., Yener S., ÖZCAN M. A., Karaoglu O., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.1, ss.23-28, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

82. The Alteration of Coagulation in Patients with Thyroid Dysfunction

AKINCI B., ÇÖMLEKÇİ A., ÖZCAN M. A.

RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY , cilt.5, sa.1, ss.50-57, 2011 (ESCI) Sürdürülebilir Kalkınma

83. Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome.

AKINCI B., ÇELTİK A., Yuksel F., Genc S., Yener S., SEÇİL M., et al.

Diabetes research and clinical practice , cilt.91, sa.1, ss.26-31, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. Acute Phase Reactants Predict the Risk of Amputation in Diabetic Foot Infection

AKINCI B., Yener S., Yesil S., Yapar N., Kucukyavas Y., BAYRAKTAR F.

JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION , cilt.101, sa.1, ss.1-6, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

85. Management of gestational diabetes by physicians in Turkey.

AKINCI B., Tosun P., Bekci E., Yener S., DEMİR T., Yesil S.

Primary care diabetes , cilt.4, sa.3, ss.173-80, 2010 (Hakemli Dergi) Sürdürülebilir Kalkınma

86. The effect of creatinine clearance on the short-term outcome of neuropathic diabetic foot ulcers

AKINCI B., Yesil S., BAYRAKTAR F., Kucukyavas Y., Yener S., ÇÖMLEKÇİ A., et al.

PRIMARY CARE DIABETES , cilt.4, sa.3, ss.181-185, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Prediction of developing metabolic syndrome after gestational diabetes mellitus.

AKINCI B., ÇELTİK A., Yener S., Yesil S.

Fertility and sterility , cilt.93, sa.4, ss.1248-54, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

88. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.

ÇÖMLEKÇİ A., Yener S., Ertilav S., SEÇİL M., AKINCI B., DEMİR T., et al.

Endocrine , cilt.37, sa.1, ss.40-6, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. Allergic reactions to human insulin: a review of current knowledge and treatment options.

AKINCI B., Yener S., BAYRAKTAR F., Yesil S.

Endocrine , cilt.37, sa.1, ss.33-9, 2010 (SCI-Expanded, Scopus)

90. Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas

Yener S., Ertilav S., SEÇİL M., Demir T., AKINCI B., Kebapcilar L., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.33, sa.1, ss.32-36, 2010 (SCI-Expanded, Scopus)

91. Predictors of amputation in diabetics with foot ulcer: Single center experience in a large Turkish cohort

Yesil S., AKINCI B., Yener S., BAYRAKTAR F., Karabay O., HAVITÇIOĞLU H., et al.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.8, sa.4, ss.286-295, 2009 (SCI-Expanded, Scopus)

92. Recurrent Cushing's Syndrome after Adrenal Autotransplantation

Yesil S., Demir T., AKINCI B., Ozdogan O., Gazioglu N., Hatemi H.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.117, sa.9, ss.470-472, 2009 (SCI-Expanded, Scopus)

93. Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation.

DEMİR T., AKINCI B., ÇÖMLEKÇİ A., Karaoglu O., ÖZCAN M. A., Yener S., et al.

Clinical endocrinology , cilt.71, sa.3, ss.446-50, 2009 (SCI-Expanded, Scopus)

94. Natural course of benign adrenal incidentalomas in subjects with extra-adrenal malignancy

Yener S., Ertilav S., SEÇİL M., AKINCI B., DEMİR T., ÇÖMLEKÇİ A., et al.

ENDOCRINE , cilt.36, sa.1, ss.135-140, 2009 (SCI-Expanded)

95. Reduction of Major Amputations after Starting a Multidisciplinary Diabetic Foot Care Team: Single Centre Experience from Turkey

Yesil S., AKINCI B., Bayraktar F., Havitcioglu H., Karabay O., Yapar N., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.117, sa.7, ss.345-349, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

96. Use of metformin in Pregnancy:A Survey of Turkish Physicians’s Attidues.

AKINCI B., TOSUN TAŞAR P., BEKÇİ E., YENER A. S., DEMİR T., YEŞİL S.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , ss.25-28, 2009 (Scopus)

97. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma

Yener S., Genc S., AKINCI B., SEÇİL M., DEMİR T., ÇÖMLEKÇİ A., et al.

ENDOCRINE , cilt.35, sa.3, ss.365-370, 2009 (SCI-Expanded)

98. Serum sickness-like reactions associated with type III insulin allergy responding to plasmapheresis

Bayraktar F., AKINCI B., DEMİRKAN F., Yener S., Yesil S., Kirmaz C., et al.

DIABETIC MEDICINE , cilt.26, sa.6, ss.659-660, 2009 (SCI-Expanded, Scopus)

99. Hypercalcemia due to Graves' disease in a patient with thyroid hemiagenesis.

Kebapçilar L., Akinci B., Demir T., Bayraktar F., Yeşil S.

Kulak burun boǧaz ihtisas dergisi : KBB = Journal of ear, nose, and throat , cilt.19, sa.3, ss.159-162, 2009 (Scopus, TRDizin)

100. Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels.

Yener S., Comlekci A., AKINCI B., SEÇİL M., Demir T., Ertilav S., et al.

Journal of endocrinological investigation , cilt.32, sa.4, ss.338-43, 2009 (SCI-Expanded, Scopus)

101. Advanced Age and Mild Thyrotoxicosis are Associated with Nodular Goiter in Graves Disease

YENER A. S., BAYRAKCI N., AKINCI B., DEMİR T., SEVİNÇ A. İ., ÖZDOĞAN Ö., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.13, sa.1, ss.1-4, 2009 (Scopus)

102. Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.

AKINCI B., Comlekci A., Tankurt E.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association , cilt.117, sa.3, ss.142-5, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

103. A Case of Gitelman's Syndrome Presenting with Extreme Hypokalaemia and Paralysis

AKINCI B., Celik A., Saygili F., Yesil S.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.117, sa.2, ss.69-71, 2009 (SCI-Expanded, Scopus)

104. Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications

Yener S., ÇÖMLEKÇİ A., AKINCI B., DEMİR T., YÜKSEL F., ÖZCAN M. A., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.18, sa.4, ss.266-271, 2009 (SCI-Expanded, Scopus)

105. BENEFICIAL EFFECT OF ENDOCRINOLOGIST-PERFORMED ULTRASONOGRAPHY ON PREOPERATIVE PARATHYROID ADENOMA LOCALIZATION

AKINCI B., DEMİR T., Yener S., ÇÖMLEKÇİ A., Binicier O., ÖZDOĞAN Ö., et al.

ENDOCRINE PRACTICE , cilt.15, sa.1, ss.17-23, 2009 (SCI-Expanded, Scopus)

106. Soluble CD40 ligand plasminogen activator inhibitor 1 and thrombin activatable fibrinolysis inhibitor 1 antigen in normotensive type 2 diabetic subjects without diabetic complications Effects of metformin and rosiglitazone

YENER A. S., ÇÖMLEKÇİ A., AKINCI B., DEMİR T., YÜKSEL F., ÖZCAN M. A., et al.

Med Princ Pract , 2009 (Hakemli Dergi) Sürdürülebilir Kalkınma

107. Use of metformin in pregnancy: A survey of Turkish physicians' attitudes

AKINCI B., Tosun P., Bekçi E., Yener S., DEMİR T., Yeşil S.

Turkish Journal of Endocrinology and Metabolism , cilt.13, sa.2, ss.25-28, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Evaluation of Insulin Resistance in Normoglycemic Patients with Coronary Artery Disease

Deveci E., Yesil M., AKINCI B., Yesil S., Postaci N., Arikan E., et al.

CLINICAL CARDIOLOGY , cilt.32, sa.1, ss.32-36, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

109. An adult case of diabetic ketoacidosis presenting with cerebral edema

AKINCI B., ÇÖMLEKÇİ A., Yener S., MEN S.

Turkish Journal of Endocrinology and Metabolism , cilt.13, sa.1, ss.16-17, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes

AKINCI B., Demir T., ÇELTİK A., BARIŞ M. M., Yener S., ÖZCAN M. A., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.82, sa.2, ss.172-178, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?

AKINCI B., ÇELTİK A., Yener S., Yesil S.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.82, sa.2, ss.219-225, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. Severe hypocalcaemia because of osteoblastic prostate carcinoma metastases

Yener S., Demir O., ÖZDOĞAN Ö., AKINCI B., Yesil S.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.62, sa.10, ss.1630-1631, 2008 (SCI-Expanded, Scopus)

113. Alterations of coagulation in metformin intoxication.

AKINCI B., Yener S., BENGİ G., Yesil S.

Hormones (Athens, Greece) , cilt.7, sa.4, ss.325-9, 2008 (Scopus)

114. Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy

AKINCI B., DEMİR T., Saygili S., Yener S., ALACACIOĞLU İ., Saygili F., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.81, sa.1, ss.93-96, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

115. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients

Akar S., CAN G., Binicier O., AKSU K., AKINCI B., Solmaz D., et al.

CLINICAL RHEUMATOLOGY , cilt.27, sa.7, ss.859-865, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

116. Management of hyperglycemia in gestational diabetes mellitus

AKINCI B., Yener S., ÇELTİK A., Sevindik G., Yesil S.

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , cilt.2, sa.2, ss.123-128, 2008 (ESCI, Scopus) Sürdürülebilir Kalkınma

117. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.

AKINCI B., ÇÖMLEKÇİ A., Yener S., BAYRAKTAR F., DEMİR T., ÖZCAN M. A., et al.

Archives of medical research , cilt.39, sa.4, ss.397-401, 2008 (SCI-Expanded, Scopus)

118. Familial hypobetalipoproteinemia in a Turkish family with hereditary spastic paraplegia

Hooper A. J., AKINCI B., ÇÖMLEKÇİ A., Burnett J. R.

CLINICA CHIMICA ACTA , cilt.390, ss.152-155, 2008 (SCI-Expanded, Scopus)

119. Evaluation of markers of inflammation, insulin resistance and endothelial dysfunction in children at risk for overweight

Akinci G., AKINCI B., COŞKUN Ş., Bayindir P., HEKİMSOY Z., Ozmen B.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.7, sa.2, ss.156-162, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

120. Serum transforming growth factor-beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone

Yener S., ÇÖMLEKÇİ A., AKINCI B., AKAN P., DEMİR T., BAYRAKTAR F., et al.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.7, sa.1, ss.70-76, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

121. Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders

AKINCI B., Yesil S.

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , cilt.2, sa.1, ss.57-61, 2008 (ESCI, Scopus) Sürdürülebilir Kalkınma

122. The effect of levothyroxine suppression therapy for benign thyroid nodules on bone metabolism in premenopausal women Menopoz öncesinde selim tiroid nodülleri için uygulanan levotiroksin supresyon tedavisinin kemik metabolizmasina etkisi.

AKINCI B., Demir T., Cömlekçi A., Karaoǧlu O., Seçil M., Yeşil S.

Kulak burun boǧaz ihtisas dergisi : KBB = Journal of ear, nose, and throat , cilt.18, sa.4, ss.232-237, 2008 (Scopus, TRDizin) Sürdürülebilir Kalkınma

123. Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis

Yener S., AKARSU M., Demir T., AKINCI B., Sagol Ö., Bayraktar F., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.30, sa.10, ss.810-819, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

124. Atherosclerosis risk factors in children of parents with the metabolic syndrome

Akinci G., COŞKUN Ş., AKINCI B., HEKİMSOY Z., Bayindir P., ONUR E., et al.

ATHEROSCLEROSIS , cilt.194, sa.2, 2007 (SCI-Expanded, Scopus)

125. Amelanotic melanoma misdiagnosed as a diabetic foot ulcer

Yesil S., Demir T., AKINCI B., Pabuccuoglu U., Ilknur T., Saklamaz A.

JOURNAL OF DIABETES AND ITS COMPLICATIONS , cilt.21, sa.5, ss.335-337, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

126. Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients

AKINCI B., Comlekci A., Yener S., Demir T., Ozcan M. A., Bayraktar F., et al.

ENDOCRINE JOURNAL , cilt.54, sa.4, ss.593-599, 2007 (SCI-Expanded, Scopus)

127. Low transforming growth factor-β1 serum levels in idiopathic male osteoporosis

AKINCI B., Bayraktar F., Saklamaz A., Demir T., Yener S., Comlekci A., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.30, sa.5, ss.350-355, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

128. The clinical, hematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey

Demirkan F., Alacacioglu İ., Ozsan G. H., Piskin O., AKINCI B., Ozcan M. A., et al.

LEUKEMIA RESEARCH , cilt.31, 2007 (SCI-Expanded, Scopus)

129. Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus

Yener S., Demir T., AKINCI B., Bayraktar F., Kebapcilar L., Ozcan M. A., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.76, sa.2, ss.193-198, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

130. Syndrome of inappropriate antidiuretic hormone secretion in a patient with advanced bladder cancer

Alacacioǧlu A., AKINCI B., Tarhan O., Gerçeker E., Başaran K., ÖZTOP İ., et al.

Turkish Journal of Cancer , cilt.37, sa.2, ss.69-71, 2007 (Scopus) Sürdürülebilir Kalkınma

131. Frequency and severity of musculoskeletal symptoms in humans during an outbreak of trichinellosis caused by Trichinella britovi.

Akar S., Gurler O., Pozio E., Onen F., SARI İ., Gerceker E., et al.

The Journal of parasitology , cilt.93, sa.2, ss.341-4, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

132. Case of leucocytoclastic vasculitis due to T-Cell rich B-Cell lymphoma

AKINCI B., Ceneli S., Piskin O., Kargi A., ALACACIOĞLU İ., ÖZCAN M. A.

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , cilt.24, sa.1, ss.65-69, 2007 (SCI-Expanded, TRDizin)

133. Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient

AKINCI B., Yesil S., Atabey A., Ilgezdi S.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.115, sa.2, ss.143-145, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

134. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement

AKINCI B., Comlekci A., Ozcan M. A., Demir T., Yener S., DEMİRKAN F., et al.

ENDOCRINE JOURNAL , cilt.54, sa.1, ss.45-52, 2007 (SCI-Expanded, Scopus)

135. The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: A single institution experience from Turkey

DEMİRKAN F., Alacacioglu İ., Piskin O., Ozsan G. H., AKINCI B., Ozcan M. A., et al.

LEUKEMIA & LYMPHOMA , cilt.48, sa.7, ss.1372-1378, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

136. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism.

AKINCI B., ÇÖMLEKÇİ A., Yener S., DEMİR T., BAYRAKTAR F., YÜKSEL F., et al.

Hormones (Athens, Greece) , cilt.6, sa.4, ss.327-333, 2007 (SCI-Expanded, Scopus)

137. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism

Kebapcilar L., AKINCI B., Bayraktar F., Comlekci A., Solak A., Demir T., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.16, sa.6, ss.432-436, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

138. Cushing's syndrome due to ectopic CRH secretion by adrenal pheochromocytoma accompanied by renal infarction.

Bayraktar F., Kebapcilar L., Kocdor M. A., Asa S. L., Yesil S., Canda S., et al.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association , cilt.114, sa.8, ss.444-7, 2006 (SCI-Expanded, Scopus)

139. Mesalazine-induced myopericarditis in a patient with ulcerative colitis

Doganay L., AKINCI B., Pekel N., Simsek I., Akpinar H.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , cilt.21, sa.2, ss.199-200, 2006 (SCI-Expanded, Scopus)

140. A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations.

Akar S., Goktay Y., AKINCI B., Tekis D., Biberoglu K., Birlik M., et al.

Rheumatology international , cilt.25, sa.1, ss.60-4, 2005 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 52

1. Loss of visceral adipose tissue may lead to a shortened aortomesenteric distance in congenital generalized lipodystrophy

ÜNAL M. Ç., UNCUOĞLU F., GÜNGÖR SEMİZ G., ARAYICI M. E., YENER A. S., ALTAY C., et al.

25th European Congress of Endocrinology, 13 Mayıs 2023, (Özet Bildiri)

2. Panniculitis-associated acquired generalized lipodystrophy in a case with dermatomyositis/systemic lupus erythematosus overlap syndrome

Çoşkuner D., AKINCI B., GÜNGÖR SEMİZ G., ÜNAL M. Ç., BİRLİK A. M., ALTAY C., et al.

Endobridge 2021, 21 Ekim 2021, (Özet Bildiri)

3. Acquired Generalized Lipodystrophy Induced by Nivolumab in a Patient with Metastatic Lung Cancer

ÜNAL M. Ç., GÜNGÖR SEMİZ G., ÖZDOĞAN Ö., ALTAY C., ÇÖMLEKÇİ A., AKINCI B.

Endobridge 2021, 21 - 24 Ekim 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

4. DISEASE ACTIVITY CORRELATES WITH INSULIN RESISTANCE AND ADIPOCYTOKINES IN PATIENTS WITH DMARD-NAIVE RHEUMATOID ARTHRITIS

Taylan A., Toprak B., AKINCI B., Birlik M., Arslan F. D., Gundogdu B., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.642-643, (Özet Bildiri)

5. Konjenital Jeneralize Lipodistrofi Tip 1 Tanılı bir olguda Rekombinant İnsan Leptin (Metreleptin) Tedavi Deneyimi

ÖZEN S., GÖKŞEN ŞİMŞEK R. D., ONAY H., ER E., ATİK T., ATA A., et al.

23. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Türkiye, 17 - 21 Nisan 2019, (Özet Bildiri)

6. A rare case of Diabetes mellitus in an Adolescent: Partial Lipodystrophy

ÖZEN S., ATA A., GÖKŞEN ŞİMŞEK R. D., AKINCI B., ALTAY C., DARCAN Ş.

The 57th Annual ESPE Meeting, 27 - 29 Eylül 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. Metabolic deterioration during prospective follow-up in an extremely rare case of congenital generalized lipodystrophy type 4

ÖZGEN SAYDAM B., ADIYAMAN S. C., ÖNTAN M. S., AKINCI B.

Endobridge 2018, Antalya, Türkiye, 25 Ekim 2018, (Özet Bildiri)

8. Burden of illness associated with generalised lipodystrophy (GL) in leptin replacement therapy-naive patients: a longitudinal medical chart review study

AKINCI B., Oral E., Neidert A., Rus D., Cheng W., Thompson-Leduc P., et al.

54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Berlin, Almanya, 1 - 05 Ekim 2018, cilt.61, (Özet Bildiri)

9. Osteoprotegrin Interacts With Biomarkers and Cytokines That Have Roles in Osteoporosis, Skin Fibrosis and Vasculopathy in Systemic Sclerosis: A Potential Multifaceted Relationship Between OPG/RANKL/TRAIL and WNT Inhibitors

TAYLAN A., BİRLİK A. M., KENAR G., TOPRAK B., GÜNDOĞDU B., GÜRLER O., et al.

XVII. Mediterranean Congress of Rheumatology, İtalya, 12 - 14 Nisan 2018

10. Liver Damage in Lipodystrophy and Impact of Metreleptin: Experience from a Large Retrospective Review

AKINCI B., Oral E. A., Neidert A., Rus D., Cheng W., Yang M., et al.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri)

11. Lipodistrofi hastalarında MRG ile böbrek hacim ölçümü

ALTAY C., ARSLAN A., ÇAVDAR Ü., Şimşir I. Y., ŞARER YÜREKLİ B. P., ÖZEN S., et al.

38. Ulusal Radyoloji Kongresi TURKRAD2017, Türkiye, 31 Ekim - 04 Kasım 2017, (Özet Bildiri)

12. Newly diagnosed MEN2B syndrome in a patient with history of hypogonadism

OZER M., CAVDAR U., ÖZGEN SAYDAM B., DEMİR T., AKINCI B.

Endobridge, 19 - 22 Ekim 2017, (Özet Bildiri)

13. Atypical LMNA mutation in EXON11 associated with a milder clinical outcome in Dunnigan-type familial partial lipodystrophy

ÖZGEN SAYDAM B., CAVDAR U., ALTAY C., ONAY H., YILDIRIM SIMSIR I., DEMİR T., et al.

2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, Türkiye, 23 - 25 Şubat 2017, (Özet Bildiri)

14. Kazanılmış Parsiyel Lipodistrofide ağır metabolik komplikasyonlar

Saydam B. Ö., Sönmez M., Şimşir Yıldırım I., KULAKSIZOĞLU M., HEKİMSOY Z., Çavdar U., et al.

39.Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Türkiye, 3 - 07 Mayıs 2017, (Özet Bildiri)

15. Dunnigan Tipi Ailesel Parisyel Lipodistrofide Hafif Klinik Bulgular İle İlişkili Atipik Ekzon 11 LMNA Mutasyonu

ÇAVDAR Ü., ALTAY C., ONAY H., YILDIRIM ŞİMŞİR I., DEMİR T., AKINCI B.

2. Ege Endokrin Hastalıkları ve Genetik Sempozyumu, Türkiye, 23 - 25 Şubat 2017, (Özet Bildiri)

16. A rare case of thyrotoxic periodic paralysis with accompanying transient hyperglycemia

ÖZGEN SAYDAM B., ÇAVDAR Ü., AKINCI B., DEMİR T.

Endobridge 2016, 20 - 23 Ekim 2016, (Özet Bildiri)

17. In vivo assessment of the early morphological changes in cases with insulin dependent diabetes mellitus using optical coherence tomography angiography

ÖZTÜRK A. T., KAYA M., AYHAN Z., AKINCI B., ÖNER F. H.

16th EURETINA Congress, COPENHAGEN, Danimarka, 8 - 11 Eylül 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

18. In vivo assessment of the early morphological changes seen in cases with insulin dependent diabetes mellitus using optical coherence tomography angiography

ÖZTÜRK A. T., KAYA M., AYHAN Z., ÖNER F. H., AKINCI B.

16th Euretina Congress, Kopenhag, Danimarka, 8 - 11 Eylül 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Konjeni tal Jenerali ze Li podi strofi Olgusunda Türki ye de İlk Metrelepti n Uygulaması iİlk 6 ay Sonuçlarımız

ŞİMŞİR YILDIRIM I., AKINCI B., ŞARER YÜREKLİ B. P., DEMİR T., ERDOĞAN M., ÇETİNKALP Ş., et al.

38. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Türkiye, 11 Mayıs - 15 Haziran 2016

20. Konjenital jeneralize lipodistrofi olgusunda Türkiye’de ilk metreleptin uygulaması: ilk 6 ay sonuçlarımız

Şimşir I. Y., AKINCI B., ŞARER YÜREKLİ B. P., DEMİR T., ERDOĞAN M., ÇETİNKALP Ş., et al.

38. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.150-152, (Özet Bildiri)

21. Lipodistrofi hastalarında serum leptin ve adiponektin düzeylerinin metabolik parametrelerle ilişkisi

DEMİR L., AKINCI G., ONAY H., ÖZEN S., ATİK T., ÇALAN M., et al.

Uluslararası katılımlı XVI. Klinik Biyokimya Kongresi & IATDMCT Regional Meeting, Kuşadası, Türkiye, İzmir, Türkiye, 5 - 08 Mayıs 2016, (Özet Bildiri)

22. Lipodistrofi hastalarında Manyetik Rezonans Spektroskopi ile karaciğer yağ içeriğinin kantitatif olarak gösterilmesi

ALTAY C., SEÇİL M., DEMİR T., AKINCI B.

TMRD, Türkiye, 5 - 01 Mayıs 2016

23. Genetic Analysis of Lipodystrophies and Novel Mutations

ONAY H., AKINCI B., ATİK T., DEMİR T., ÖZEN S.

I. Ege Endokrinolojik hastalıklar ve Genetik Sempozyumu, Türkiye, 25 - 27 Şubat 2015

24. Familial Partial Lipodystrophy Linked to a Novel Peroxisome Proliferator Activated Receptor PPARG Mutation H449L

DEMİR T., ONAY H., DAVİD S., AYŞE K., ŞENAY E., ALTAY C., et al.

. I. Ege Endokrinolojik hastalıklar ve Genetik Sempozyumu, Türkiye, 25 - 27 Şubat 2015

25. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor g mutation H449L

DEMİR T., ONAY H., DAVİD S S., KUBAT ÜZÜM A., SENAY E., ALTAY C., et al.

17th European Congress of Endocrinology 2015, Dublin, İrlanda, 15 - 17 Mayıs 2015, (Özet Bildiri)

26. Lipodistrofilerin Genetik Analizi ve Saptanan Yeni Mutasyonlar

ONAY H., AKINCI B., ATİK T., DEMİR T., ÖZEN S.

I. Ege Endokrin Hastalıkları ve Genetik Sempozyumu, Türkiye, 25 - 27 Şubat 2015

27. KONJENİTAL JENERALİZE LİPODİSTROFİ DE HASTALIK SEBEBİ MUTASYONLAR KLİNİK ÖZELLİKLER VE KOMPLİKASYONLAR

AKINCI B., ONAY H., DEMİR T.

37. TÜRKİYE ENDOKRİNOLOJİ VE METABOLİZMA HASTALIKLARI KONGRESİ, Antalya, Türkiye, 6 - 10 Mayıs 2015, (Özet Bildiri)

28. Konjenital jenaralize lipodistrofili hastalara ait tüm vücut MRG de mekanik yağ doku dağılımının araştırılması

ALTAY C., AKINCI B., SEÇİL M., ŞİMŞİR I., AKINCI G., ABACI A., et al.

35. Ulusal Radyoloji Kongresi, Türkiye, 11 - 15 Kasım 2014 Sürdürülebilir Kalkınma